Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,356 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[An unusual mediastinal mass].
Bousquet E, Pontier S, Hermant C, Rouquette I, Meyer N, Didier A, Mazieres J. Bousquet E, et al. Among authors: meyer n. Rev Mal Respir. 2014 Sep;31(7):624-7. doi: 10.1016/j.rmr.2013.11.004. Epub 2013 Dec 11. Rev Mal Respir. 2014. PMID: 25239585 French.
[Dermatologic toxicities of immune checkpoint inhibitors].
Sibaud V, Boulinguez S, Pagès C, Riffaud L, Lamant L, Chira C, Boyrie S, Vigarios E, Tournier E, Meyer N. Sibaud V, et al. Among authors: meyer n. Ann Dermatol Venereol. 2018 May;145(5):313-330. doi: 10.1016/j.annder.2018.01.047. Epub 2018 Apr 18. Ann Dermatol Venereol. 2018. PMID: 29678394 Review. French.
[Treatment of patients with brain metastases from a melanoma].
Modesto A, Chira C, Sol JC, Lubrano V, Boulinguez S, Pagès C, Sibaud V, Gomez-Roca C, Moyal É, Meyer N. Modesto A, et al. Among authors: meyer n. Cancer Radiother. 2019 Apr;23(2):147-150. doi: 10.1016/j.canrad.2018.05.006. Epub 2019 Mar 21. Cancer Radiother. 2019. PMID: 30904418 Review. French.
Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients.
Dufau C, Genais M, Mucher E, Jung B, Garcia V, Montfort A, Tosolini M, Clarke CJ, Medin JA, Levade T, Delord JP, Meyer N, Pancaldi V, Andrieu-Abadie N, Ségui B. Dufau C, et al. Among authors: meyer n. Front Immunol. 2024 Jul 29;15:1421432. doi: 10.3389/fimmu.2024.1421432. eCollection 2024. Front Immunol. 2024. PMID: 39136013 Free PMC article.
Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.
Masson Regnault M, Ofaiche J, Boulinguez S, Tournier E, Rochaix P, Paul C, Lamant L, Meyer N. Masson Regnault M, et al. Among authors: meyer n. J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e73-e74. doi: 10.1111/jdv.13733. Epub 2016 Jun 3. J Eur Acad Dermatol Venereol. 2017. PMID: 27256718 No abstract available.
1,356 results